Charlotte O'Brien-Gore1, Elizabeth H Gray1, Lucy E Durham1, Leonie S Taams1, Bruce W Kirkham2. 1. Centre for Inflammation Biology & Cancer Immunology, Dept. Inflammation Biology, School of Immunology & Microbial Sciences, King's College London, London, SE1 1UL, UK. 2. Rheumatology Department, Guy's & St Thomas' NHS Foundation Trust, London, SE1 9RT, UK. bruce.kirkham@gstt.nhs.uk.
Abstract
PURPOSE OF REVIEW: The recognition that IL-17 is produced by many lymphoid-like cells other than CD4+ T helper (Th17) cells raises the potential for new pathogenic pathways in IBD/psoriasis/SpA. We review recent knowledge concerning the role of unconventional and conventional lymphocytes expressing IL-17 in human PsA and axSpA. RECENT FINDINGS: Innate-like lymphoid cells, namely gamma delta (γδ) T-cells, invariant natural killer T (iNKT) cells and mucosal-associated invariant T (MAIT) cells, together with innate lymphoid cells (ILCs) are found at sites of disease in PsA/SpA. These cells are often skewed to Type-17 profiles and may significantly contribute to IL-17 production. Non-IL-23 dependent IL-17 production pathways, utilising cytokines such as IL-7 and IL-9, also characterise these cells. Both conventional CD4 and CD8 lymphocytes show pathogenic phenotypes at sites of disease. A variety of innate-like lymphoid cells and conventional lymphocytes contribute towards IL-17-mediated pathology in PsA/SpA. The responses of these cells to non-conventional immune and non-immune stimuli may explain characteristic clinical features of these diseases and potential therapeutic mechanisms of therapies such as Jak inhibitors.
PURPOSE OF REVIEW: The recognition that IL-17 is produced by many lymphoid-like cells other than CD4+ T helper (Th17) cells raises the potential for new pathogenic pathways in IBD/psoriasis/SpA. We review recent knowledge concerning the role of unconventional and conventional lymphocytes expressing IL-17 in human PsA and axSpA. RECENT FINDINGS: Innate-like lymphoid cells, namely gamma delta (γδ) T-cells, invariant natural killer T (iNKT) cells and mucosal-associated invariant T (MAIT) cells, together with innate lymphoid cells (ILCs) are found at sites of disease in PsA/SpA. These cells are often skewed to Type-17 profiles and may significantly contribute to IL-17 production. Non-IL-23 dependent IL-17 production pathways, utilising cytokines such as IL-7 and IL-9, also characterise these cells. Both conventional CD4 and CD8 lymphocytes show pathogenic phenotypes at sites of disease. A variety of innate-like lymphoid cells and conventional lymphocytes contribute towards IL-17-mediated pathology in PsA/SpA. The responses of these cells to non-conventional immune and non-immune stimuli may explain characteristic clinical features of these diseases and potential therapeutic mechanisms of therapies such as Jak inhibitors.
Authors: Anne M Loos; Shanshan Liu; Celia Segel; Daniel A Ollendorf; Steven D Pearson; Jeffrey A Linder Journal: J Am Acad Dermatol Date: 2018-02-10 Impact factor: 11.527
Authors: William O'Connor; Masahito Kamanaka; Carmen J Booth; Terrence Town; Susumu Nakae; Yoichiro Iwakura; Jay K Kolls; Richard A Flavell Journal: Nat Immunol Date: 2009-06 Impact factor: 25.606
Authors: Leonie S Taams; Kathryn J A Steel; Ushani Srenathan; Lachrissa A Burns; Bruce W Kirkham Journal: Nat Rev Rheumatol Date: 2018-08 Impact factor: 20.543
Authors: Dennis G McGonagle; Iain B McInnes; Bruce W Kirkham; Jonathan Sherlock; Robert Moots Journal: Ann Rheum Dis Date: 2019-07-05 Impact factor: 19.103
Authors: Jared Liu; Sugandh Kumar; Julie Hong; Zhi-Ming Huang; Diana Paez; Maria Castillo; Maria Calvo; Hsin-Wen Chang; Daniel D Cummins; Mimi Chung; Samuel Yeroushalmi; Erin Bartholomew; Marwa Hakimi; Chun Jimmie Ye; Tina Bhutani; Mehrdad Matloubian; Lianne S Gensler; Wilson Liao Journal: Front Immunol Date: 2022-03-02 Impact factor: 7.561